Mutant MHC class II epitopes drive therapeutic immune responses to cancer-Reference-Cited by-同舟云学术

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

Published:2015-04-22 Issue:7549 Volume:520 Page:692-696
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Kreiter Sebastian,Vormehr Mathias,van de Roemer Niels,Diken Mustafa,Löwer Martin,Diekmann Jan,Boegel Sebastian,Schrörs Barbara,Vascotto Fulvia,Castle John C.,Tadmor Arbel D.,Schoenberger Stephen P.,Huber Christoph,Türeci Özlem,Sahin Ugur

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14426.pdf

Reference30 articles.

1. Castle, J. C. et al. Exploiting the mutanome for tumor vaccination. Cancer Res. 72, 1081–1091 (2012).

2. Castle, J. C. et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics 15, 190 (2014).

3. Holtkamp, S. et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108, 4009–4017 (2006).

4. Kreiter, S. et al. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J. Immunol. 180, 309–318 (2008).

5. Kuhn, A. N. et al. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo. Gene Ther. 17, 961–971 (2010).

Cited by 1012 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA-based cancer therapeutics;mRNA Therapeutics;2025

2. Introduction to mRNA and mRNA-based therapeutics;mRNA Therapeutics;2025

3. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

4. Self-assembly nanoparticles potentiate in-situ tumor vaccine of radiotherapy by regulating tumor immunogenicity and tumor-associated macrophages;Chemical Engineering Journal;2024-10

5. Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis;Journal of Nanobiotechnology;2024-09-14